NCT02153229 2025-12-26
MPM-PDT
Abramson Cancer Center at Penn Medicine
Phase 2 Active not recruiting
Clinical Trials
13 trialsNCT04681417 2025-11-28
RETINO 2018
Institut Curie
Phase 2/3 Recruiting
NCT07131345 2025-08-20
Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma
National Cancer Center, China
Phase 1/2 Not yet recruiting
NCT02649829 2025-04-29
MESODEC
University Hospital, Antwerp
Phase 1/2 Completed
NCT06416930 2024-05-16
Study of Cadonilimab Combined With Chemotherapy in Recurrent / Refractory Pleural Mesothelioma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Not yet recruiting
NCT03874897 2024-04-30
Chimeric Antigen Receptor T Cells Targeting claudin18.2 in Solid Tumors.
Peking University
Phase 1 Completed
NCT05809336 2023-04-12
Gut Microbial Metabolites Inosine Combined With PD-1/PD-L1 Inhibitor for Patients With Malignant Advanced Solid Tumors
Beijing Friendship Hospital
Phase 2/3 Completed
NCT04214717 2023-03-28
DC-CIK
Yantai Yuhuangding Hospital
Phase NA Unknown
NCT04214730 2023-03-28
NK
Yantai Yuhuangding Hospital
Phase NA Unknown
NCT05388279 2023-03-23
A Clinical Study to Evaluate the Safety and Tolerability of JS012 in Advanced or Metastatic Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
Phase 1 Terminated
NCT02137928 2014-12-19
Carboplatin Periocular Injection for Retinoblastoma
Sun Yat-sen University
Phase 3 Unknown
NCT01899066 2014-05-13
Efficacy Study of Lucentis in the Treatment of Retinoblastoma
Sun Yat-sen University
Phase 2 Unknown
NCT00003974 2011-03-07
Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma
Roswell Park Cancer Institute
Phase 1 Completed